Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
JAMA Network Open , 3(12):1-11
Lectura recomendada:
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
JAMA Network Open , 3(12):1-11
¿CUAL DE LOS SIGUIENTES AGENTES ANTIHIPERTENSIVOS SE ASOCIA CON RIESGO AUMENTADO DE CANCER DE PIEL?
Introducción:
La exposición a la radiación ultravioleta (UV) es el factor de riesgo ambiental más importante para el cáncer de piel. La fototoxicidad inducida por drogas, es decir el daño de la piel atribuible a interacciones entre la radiación UV y diversos fármacos, puede incrementar el efecto carcinogénico de la exposición al sol.
Lectura recomendada:
Association between Antihypertensive Medications and Risk of Skin Cancer in People Older than 65 Years: A Population-based Study
Canadian Medical Association Journal, 193(15):508-516
Lectura recomendada:
Associations of Treated and Untreated Human Papillomavirus Infection with Preterm Delivery and Neonatal Mortality: A Swedish Population-based Study
PLoS Medicine, :1-22
Lectura recomendada:
Associations of Treated and Untreated Human Papillomavirus Infection with Preterm Delivery and Neonatal Mortality: A Swedish Population-based Study
PLoS Medicine, :1-22
Lectura recomendada:
Intrapandemic Regional Anesthesia as Practice: a Historical Cohort Study in Patients Undergoing Breast Cancer surgery
Canadian Journal of Anaesthesia , :1-9
¿EN QUE BASAN LOS AUTORES ESTA AFIRMACION? SEÑALE LA OPCION CORRECTA.
Introducción:
Los estudios en fase III MAIA y ALCYONE, en los que se evaluó el uso de daratumumab, un inmunomodulador dirigido a las CD38 que inhibe el crecimiento de las células tumorales y provoca la apoptosis de las células del mieloma, informaron resultados positivos.
Lectura recomendada:
Sustained Minimal Residual Disease Negativity with Daratumumab in Newly Diagnosed Multiple Myeloma: MAIA and ALCYONE
Blood,
Lectura recomendada:
Sixty-Day Mortality of Patients with Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment The CAIRO4 Phase 3 Randomized Clinical Tria
JAMA Surgery ,
Lectura recomendada:
Sixty-Day Mortality of Patients with Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment The CAIRO4 Phase 3 Randomized Clinical Tria
JAMA Surgery ,
Lectura recomendada:
Sixty-Day Mortality of Patients with Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment The CAIRO4 Phase 3 Randomized Clinical Tria
JAMA Surgery ,
Lectura recomendada:
The Long-term Survival Outcomes of Gastric Cancer Patients with Total Intravenous Anesthesia or Inhalation Anesthesia: a Single-center Retrospective Cohort Study
BMC Cancer , 21(1):1-12
Lectura recomendada:
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804
Journal of Clinical Oncology,
Lectura recomendada:
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804
Journal of Clinical Oncology,
Lectura recomendada:
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804
Journal of Clinical Oncology,
Lectura recomendada:
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients with Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
Journal of Clinical Oncology, 39(10):1098-1107
Lectura recomendada:
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients with Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
Journal of Clinical Oncology, 39(10):1098-1107